147 related articles for article (PubMed ID: 8671628)
1. In vitro and in vivo recovery of IFN-gamma, but not IL-2, production by IL-12 in mice with plasma cell tumors.
Ruzek MC; Mathur A
Int Immunol; 1996 Mar; 8(3):413-22. PubMed ID: 8671628
[TBL] [Abstract][Full Text] [Related]
2. Decreased production of IL-2 and IFN-gamma by stimulated splenocytes from mice bearing plasma cell tumors is associated with alteration of DNA-binding factors.
Ruzek MC; O'Brien DP; Mathur A
Int Immunol; 1996 Dec; 8(12):1971-82. PubMed ID: 8982782
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.
Blanchard DK; Djeu JY; Klein TW; Friedman H; Stewart WE
J Immunol; 1986 Feb; 136(3):963-70. PubMed ID: 2867114
[TBL] [Abstract][Full Text] [Related]
5. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
Hunter CA; Chizzonite R; Remington JS
J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
[TBL] [Abstract][Full Text] [Related]
6. Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells.
Di Francesco P; Falchetti R; Gaziano R; Lanzilli G; Casalinuovo IA; Ravagnan G; Garaci E
Clin Exp Immunol; 1999 Dec; 118(3):428-34. PubMed ID: 10594563
[TBL] [Abstract][Full Text] [Related]
7. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
8. Specific decrease of Th1-like activity in mice with plasma cell tumors.
Ruzek MC; Mathur A
Int Immunol; 1995 Jul; 7(7):1029-35. PubMed ID: 8527400
[TBL] [Abstract][Full Text] [Related]
9. Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production.
Takayama E; Seki S; Ohkawa T; Ami K; Habu Y; Yamaguchi T; Tadakuma T; Hiraide H
J Immunol; 2000 Jun; 164(11):5652-8. PubMed ID: 10820240
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
Lees CJ; Apostolopoulos V; McKenzie IF
J Interferon Cytokine Res; 1999 Dec; 19(12):1373-9. PubMed ID: 10638706
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement.
Tanaka T; Hu-Li J; Seder RA; Fazekas de St Groth B; Paul WE
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5914-8. PubMed ID: 8100998
[TBL] [Abstract][Full Text] [Related]
12. Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.
Diaz-Sanchez D; Noble A; Staynov DZ; Lee TH; Kemeny DM
Immunology; 1993 Apr; 78(4):513-9. PubMed ID: 8495968
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Tripp CS; Wolf SF; Unanue ER
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel in vitro co-culture system for studying host response to native bacterial antigens.
Mason KM; Bigley NJ; Fink PS
J Immunol Methods; 1998 Feb; 211(1-2):147-58. PubMed ID: 9617839
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells.
Frasca D; Pucci S; Goso C; Barattini P; Barile S; Pioli C; Doria G
Mech Ageing Dev; 1997 Feb; 93(1-3):157-69. PubMed ID: 9089580
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
17. Development of IFN-gamma-producing CD8+ gamma delta+ T lymphocytes and IL-2-producing CD4+ alpha beta+ T lymphocytes during contact sensitivity.
Dieli F; Asherson GL; Sireci G; Dominici R; Sciré E; Salerno A
J Immunol; 1997 Mar; 158(6):2567-75. PubMed ID: 9058788
[TBL] [Abstract][Full Text] [Related]
18. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models.
Iwasaki M; Yu WG; Uekusa Y; Nakajima C; Yang YF; Gao P; Wijesuriya R; Fujiwara H; Hamaoka T
Int Immunol; 2000 May; 12(5):701-9. PubMed ID: 10784616
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cells inhibit immunoglobulin E synthesis in low responder SJL/J mice.
Yang M; Cao Y; Mohapatra SS
Immunology; 1998 Feb; 93(2):230-7. PubMed ID: 9616373
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.
Li XF; Takiuchi H; Zou JP; Katagiri T; Yamamoto N; Nagata T; Ono S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1993 Mar; 84(3):315-25. PubMed ID: 8098027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
